AQR Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.86M Sell
861,366
-285,013
-25% -$2.6M 0.01% 1070
2025
Q1
$9.11M Buy
1,146,379
+585,950
+105% +$4.66M 0.01% 904
2024
Q4
$3.04M Buy
560,429
+156,676
+39% +$851K ﹤0.01% 1309
2024
Q3
$2.92M Buy
403,753
+309,923
+330% +$2.24M ﹤0.01% 1317
2024
Q2
$1.01M Buy
+93,830
New +$1.01M ﹤0.01% 1750
2024
Q1
Sell
-67,042
Closed -$1.45M 2492
2023
Q4
$1.45M Sell
67,042
-7,141
-10% -$155K ﹤0.01% 1474
2023
Q3
$1.53M Buy
74,183
+63,058
+567% +$1.3M ﹤0.01% 1441
2023
Q2
$523K Sell
11,125
-2,367
-18% -$111K ﹤0.01% 1773
2023
Q1
$566K Sell
13,492
-1,916
-12% -$80.4K ﹤0.01% 1735
2022
Q4
$588K Sell
15,408
-3,962
-20% -$151K ﹤0.01% 1750
2022
Q3
$759K Sell
19,370
-38,353
-66% -$1.5M ﹤0.01% 1619
2022
Q2
$1.83M Sell
57,723
-274,023
-83% -$8.7M ﹤0.01% 1135
2022
Q1
$11M Sell
331,746
-135,621
-29% -$4.49M 0.02% 693
2021
Q4
$19.9M Sell
467,367
-66,333
-12% -$2.82M 0.04% 485
2021
Q3
$23.5M Buy
533,700
+367,529
+221% +$16.2M 0.04% 439
2021
Q2
$9.44M Buy
166,171
+155,530
+1,462% +$8.84M 0.02% 711
2021
Q1
$796K Buy
10,641
+7,091
+200% +$530K ﹤0.01% 1654
2020
Q4
$307K Buy
+3,550
New +$307K ﹤0.01% 1963
2019
Q4
Sell
-2,758
Closed -$387K 2165
2019
Q3
$387K Buy
2,758
+9
+0.3% +$1.26K ﹤0.01% 1835
2019
Q2
$497K Sell
2,749
-288
-9% -$52.1K ﹤0.01% 1729
2019
Q1
$483K Sell
3,037
-7,172
-70% -$1.14M ﹤0.01% 1815
2018
Q4
$978K Sell
10,209
-605
-6% -$58K ﹤0.01% 1524
2018
Q3
$1.53M Sell
10,814
-28,357
-72% -$4M ﹤0.01% 1516
2018
Q2
$6.13M Sell
39,171
-50,560
-56% -$7.91M 0.01% 945
2018
Q1
$14.5M Buy
89,731
+41,721
+87% +$6.72M 0.02% 676
2017
Q4
$7.91M Buy
48,010
+27,862
+138% +$4.59M 0.01% 863
2017
Q3
$1.26M Buy
20,148
+7,862
+64% +$490K ﹤0.01% 1583
2017
Q2
$978K Sell
12,286
-4,174
-25% -$332K ﹤0.01% 1680
2017
Q1
$1.17M Buy
+16,460
New +$1.17M ﹤0.01% 1610
2016
Q2
Sell
-6,306
Closed -$202K 2252
2016
Q1
$202K Sell
6,306
-5,488
-47% -$176K ﹤0.01% 2113
2015
Q4
$688K Sell
11,794
-5,369
-31% -$313K ﹤0.01% 1734
2015
Q3
$726K Buy
+17,163
New +$726K ﹤0.01% 1586